• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过普遍的产时筛查检测到的可卡因、苯丙胺和阿片类药物使用对围产期的影响。

The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening.

作者信息

Gillogley K M, Evans A T, Hansen R L, Samuels S J, Batra K K

机构信息

Department of Obstetrics and Gynecology, University of California, Davis.

出版信息

Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1535-42. doi: 10.1016/0002-9378(90)90621-d.

DOI:10.1016/0002-9378(90)90621-d
PMID:2240103
Abstract

Universal urine testing for cocaine, amphetamines, and opiates was performed on 1643 women admitted to an obstetric service for a 1-year period with 20.5% having positive results. There were 299 patients with positive toxicology results matched for race and discharge date with patients having negative toxicology and drug history. Significant differences in age, prior obstetric history, prenatal care, alcohol history, and smoking were noted between groups. There was a significant decrease in birth weight, head circumference, length, and gestational age for the drug-positive group, which was most marked in cocaine and multiple drug users. These differences persisted after we controlled for smoking, prenatal care, and prior preterm births. Differences in birth weight and head circumference remained after we controlled for gestational age. Rates of congenital anomalies and abruptio placental were similar between groups. Perinatal substance abuse is independently associated with growth retardation and prematurity. Multiple risk factors are frequently present, necessitating a comprehensive approach to prenatal care.

摘要

对1643名入住产科服务部门长达1年的女性进行了可卡因、苯丙胺和阿片类药物的常规尿液检测,结果显示20.5%的女性检测呈阳性。有299名毒理学检测结果呈阳性的患者,在种族和出院日期方面与毒理学检测结果为阴性且无药物史的患者相匹配。两组在年龄、既往产科病史、产前护理、饮酒史和吸烟方面存在显著差异。药物阳性组的出生体重、头围、身长和孕周显著降低,这在可卡因使用者和多种药物使用者中最为明显。在我们对吸烟、产前护理和既往早产情况进行控制后,这些差异仍然存在。在我们对孕周进行控制后,出生体重和头围的差异依然存在。两组之间先天性异常和胎盘早剥的发生率相似。围产期药物滥用与生长发育迟缓及早产独立相关。通常存在多种风险因素,因此需要采取全面的产前护理方法。

相似文献

1
The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening.通过普遍的产时筛查检测到的可卡因、苯丙胺和阿片类药物使用对围产期的影响。
Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1535-42. doi: 10.1016/0002-9378(90)90621-d.
2
Prenatal drug use in Minneapolis-St Paul, Minn. A 4-year trend.明尼苏达州明尼阿波利斯-圣保罗市的产前药物使用情况。一项为期4年的趋势研究。
Arch Fam Med. 1994 Jun;3(6):520-7. doi: 10.1001/archfami.3.6.520.
3
The effect of cocaine abuse on birth weight and gestational age.可卡因滥用对出生体重和孕周的影响。
Obstet Gynecol. 1988 Sep;72(3 Pt 1):351-4.
4
Effects of alcohol use, smoking, and illicit drug use on fetal growth in black infants.饮酒、吸烟和使用非法药物对黑人婴儿胎儿生长的影响。
J Pediatr. 1994 May;124(5 Pt 1):757-64. doi: 10.1016/s0022-3476(05)81371-x.
5
Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth.产前使用快克/可卡因的前瞻性匹配研究的出生结局:I. 对健康和生长的交互作用及剂量效应。
Pediatrics. 1998 Feb;101(2):229-37. doi: 10.1542/peds.101.2.229.
6
Cocaine use during pregnancy: adverse perinatal outcome.孕期使用可卡因:围产期不良结局。
Am J Obstet Gynecol. 1987 Sep;157(3):686-90. doi: 10.1016/s0002-9378(87)80029-7.
7
Temporal patterns of cocaine use in pregnancy. Perinatal outcome.孕期可卡因使用的时间模式。围产期结局。
JAMA. 1989;261(12):1741-4.
8
Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample.产前暴露于可卡因/快克的婴儿的生长情况:产前护理样本与无产前护理样本的比较。
Pediatrics. 1999 Aug;104(2):e18. doi: 10.1542/peds.104.2.e18.
9
Cocaine abuse during pregnancy: correlation between prenatal care and perinatal outcome.
Obstet Gynecol. 1989 Dec;74(6):882-5.
10
Association between patterns of maternal substance use and infant birth weight, length, and head circumference.母亲物质使用模式与婴儿出生体重、身长和头围之间的关联。
Pediatrics. 2004 Aug;114(2):e226-34. doi: 10.1542/peds.114.2.e226.

引用本文的文献

1
Perceptions of positive and negative clinician communication in obstetrical visits from the perspectives of pregnant patients who use substances.从使用药物的孕妇视角看产科就诊中临床医生积极和消极沟通的认知
PEC Innov. 2025 Apr 22;6:100394. doi: 10.1016/j.pecinn.2025.100394. eCollection 2025 Jun.
2
Improving the quality of antenatal screening and early intervention for alcohol and other drug use: protocol for a multi-stage approach to systems reform.改善产前筛查和酒精及其他药物使用的早期干预质量:系统改革的多阶段方法方案。
Addict Sci Clin Pract. 2024 Jan 5;19(1):2. doi: 10.1186/s13722-023-00434-6.
3
Characteristics and outcomes of neonatal opioid withdrawal syndrome in preterm infants: a retrospective cohort study in the current era.
早产儿新生儿阿片类药物戒断综合征的特征与结局:当代一项回顾性队列研究
J Perinatol. 2023 Jul;43(7):909-915. doi: 10.1038/s41372-023-01672-x. Epub 2023 May 15.
4
Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review.孕期母亲使用阿片类药物与先天性畸形:一项系统综述
Pediatrics. 2017 Jun;139(6). doi: 10.1542/peds.2016-4131.
5
Cocaine-induced neurodevelopmental deficits and underlying mechanisms.可卡因诱导的神经发育缺陷及其潜在机制。
Birth Defects Res C Embryo Today. 2016 Jun;108(2):147-73. doi: 10.1002/bdrc.21132.
6
Perinatal Illicit Drug and Marijuana Use.围产期非法药物和大麻使用情况。
Am J Health Promot. 2017 Jan;31(1):35-42. doi: 10.4278/ajhp.141215-QUAL-625. Epub 2016 Nov 17.
7
Methamphetamines and pregnancy outcomes.甲基苯丙胺与妊娠结局。
J Addict Med. 2015 Mar-Apr;9(2):111-7. doi: 10.1097/ADM.0000000000000101.
8
Cocaine use during pregnancy assessed by hair analysis in a Canary Islands cohort.通过在加那利群岛队列中进行毛发分析评估孕期可卡因使用情况。
BMC Pregnancy Childbirth. 2012 Jan 9;12:2. doi: 10.1186/1471-2393-12-2.
9
Universal alcohol/drug screening in prenatal care: a strategy for reducing racial disparities? Questioning the assumptions.产前保健中普遍进行酒精/药物筛查:一种减少种族差异的策略?质疑假设。
Matern Child Health J. 2011 Nov;15(8):1127-34. doi: 10.1007/s10995-010-0720-6.
10
Novel biomarkers of prenatal methamphetamine exposure in human meconium.人类胎粪中产前甲基苯丙胺暴露的新型生物标志物。
Ther Drug Monit. 2009 Feb;31(1):70-5. doi: 10.1097/FTD.0b013e318195d7cb.